UNEEG™ medical presents results at AEDD
As the 2017 People’s choice award winner of the Shark Tank competition, UNEEG™ medical was invited back to the fifteenth conference focusing on issues related to antiepileptic drug and device (AEDD) on 22-24 May in Miami, Head of Epilepsy Research, Dr Jonas Duun-Henriksen, presented our newest findings based on more than 1500 days of continuous subcutaneous EEG.
“It was a real pleasure to be back in Miami and share with the American epilepsy community that we now have the CE-mark and will pursue FDA approval as well”, Jonas said after his talk. “We experienced a lot of excitement regarding the UNEEG 24/7. Ultra long-term EEG monitoring is no doubt identified as an unmet need by the clinicians in optimization of epilepsy treatment”.